In contrast intrapulmonary administration of P2shortA or Abemaciclib alone did not reduce Ki67 or pRb levels, indicating that, at least in this experimental design, and at the concentrations of treatments chosen, tumour growth remain unaffected (Figure 7E-G). This evidence concerns the gene RB1 and neoplasm.